Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950136-04-000894
Filing Date
2004-03-29
Accepted
2004-03-29 11:12:44
Documents
12
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K file001.htm 10-K 2420083
3 GRAPHIC ebox.gif GRAPHIC 112
4 GRAPHIC html_93433chart1.jpg GRAPHIC 60662
5 GRAPHIC spacer.gif GRAPHIC 90
6 GRAPHIC xbox.gif GRAPHIC 114
7 RESEARCH COLLABORATION AND OPTION AGREEMENT file002.htm EX-10.43 364163
8 SUBSIDIARIES OF THE REGISTRANT file003.htm EX-21.1 2387
9 CONSENT OF ERNST & YOUNG LLP file004.htm EX-23.1 2720
10 CERTIFICATION file005.htm EX-31.1 8433
11 CERTIFICATION file006.htm EX-31.2 9560
12 WRITTEN STATEMENT OF THE CEO file007.htm EX-32.1 2421
13 WRITTEN STATEMENT OF THE CFO file008.htm EX-32.2 2431
  Complete submission text file 0000950136-04-000894.txt   2876056
Mailing Address FOUR SCIENCE PARK NEW HAVEN CT 06511
Business Address 4 SCIENCE PARK NEW HAVEN CT 06511 2034984210
VION PHARMACEUTICALS INC (Filer) CIK: 0000944522 (see all company filings)

EIN.: 133671221 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26534 | Film No.: 04694932
SIC: 2836 Biological Products, (No Diagnostic Substances)